Data suggest a paracrine function of IL-1beta in HL lesions and a modulatory role of IL-1R2 as a specific product of HRS cells likely to inhibit possible differentiating functions of IL-1 on the tumor cell itself, and to induce anergy in the surrounding lymphoid tissue. The gene discussed is IL1R2; the disease is neoplasm.